Insights
When to Place a Referral for Field Case Management
2 MIN READ
Genex takes the guesswork out of when to refer a case and helps get your injured employees on the road to recovery and return to work.
What's in Your Medicine Cabinet?
3 MIN READ
How many of us have medicine cabinets where we store our “you never know” items? We routinely pick up cough drops and syrups, adult and child variations of over-the-counter (OTC) pain relievers, muscle creams, bandages, even some essential oils for good measure, because, you never know when you might need something.
The Complex Landscape Surrounding High-Impact Drugs & Workers' Comp
Drugs such as topicals and combo packs see low utilization but carry exponentially higher costs.
Ask The Pharmacist: Safe Drug Disposal Methods in Workers’ Compensation
3 MIN READ
Often prescribed for moderate-to-severe pain, opioids can be highly effective medications, they can also be associated with serious risks including the potential for abuse and addiction. Patients may not be aware of the dangers of keeping unused opioids in the home and the importance of safe disposal of these medications.
Identify, Engage, Impact: Achieving Better Outcomes in Workers’ Compensation
Measuring outcomes for workers’ compensation is challenging. Return-to-work, avoidance of disability, and cost of care are metrics that have been traditionally used to determine the success of a case.
Third Party Auto Cost Drivers: Medical Inflation and More
To help understand these cost drivers, Enlyte analyzed its third party medical bill review charge data from the beginning with claims created in our bill review system from 2017 through the end of 2021. We’ve outlined Enlyte’s observation of trends in this data.
How Medical Inflation is Affecting Workers’ Compensation Claims
To help understand how medical inflation is affecting the workers’ compensation industry today, Enlyte analyzed its medical bill review data. We’ve outlined our key findings and trends to watch as this pattern continues. This data covers Q1 2017 through the end of Q4 2021.